New York Life Investment Management’s CareDx CDNA Stock Holding History

New York Life Investment Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38,076	Closed	-$457K	–	1359
2023 Q4	$457K	Sell	38,076 -878	-2%	-$7.19K	﹤0.01%	893
2023 Q3	$273K	Sell	38,954 -6,137	-14%	-$56.7K	﹤0.01%	1210
2023 Q2	$383K	Sell	45,091 -6,823	-13%	-$56.9K	﹤0.01%	1065
2023 Q1	$474K	Buy	51,914 +36,581	+239%	+$468K	0.01%	1014
2022 Q4	$175K	Buy	15,333 +1,726	+13%	+$25.6K	﹤0.01%	1181
2022 Q3	$232K	Buy	13,607 +1,000	+8%	+$21.5K	﹤0.01%	1160
2022 Q2	$271K	Buy	+12,607	New	+$350K	﹤0.01%	1182

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York Life Investment Management's CDNA Position: Q1 2024 in Review

New York Life Investment Management sold out of CareDx (CDNA) in Q1 2024, closing a stake of 38,076 shares — an estimated $457K sold.

New York Life Investment Management first reported a position in CDNA in Q2 2022 and held it in 7 quarters. The position peaked at $474K in Q1 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q1 2024.

New York Life Investment Management reported no remaining CareDx position as of Q1 2024 after selling out during the quarter.
New York Life Investment Management sold 38,076 CareDx shares in Q1 2024, an estimated $457K.
New York Life Investment Management first reported a position in CareDx in Q2 2022 and held it in 7 quarters.
New York Life Investment Management's CareDx position peaked at $474K in Q1 2023.
147 funds tracked by Wall St. Rank held CareDx as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.